Shanghai research "artificial eye" will be used for human trial this year

Release date: 2008-01-15

In 2008, a groundbreaking project known as the "Artificial Eyes" initiative from Shanghai Research is set to move into human trials. Led by Dr. Ren Qiushi, a distinguished scientist at Shanghai Jiaotong University and a Yangtze River Scholar, the visual prosthesis has successfully passed animal testing. Experimental animals with the device implanted have shown measurable responses in the cerebral cortex, indicating that they can perceive visual stimuli. If the upcoming human trials are successful, this technology could soon transition into clinical use, offering new hope to millions of blind individuals around the world.

The primary goal of the project is to restore vision for patients suffering from retinal diseases like age-related macular degeneration and retinitis pigmentosa. The research integrates multiple disciplines, including visual mechanisms, information coding, processing of retinal neural networks, visual computing, and the development of visual prostheses based on optic nerve stimulation. It also involves biocompatible materials and bio-microelectronic devices, making it a multidimensional scientific endeavor.

While the success of cochlear implants has inspired progress in sensory restoration, the visual system presents a far greater challenge. Approximately 80% of the information processed by the human body comes through vision, and about 60% of the brain's cortical cells are dedicated to visual processing. As such, understanding how the visual system interprets signals remains an ongoing area of research. Current visual prostheses use electrode arrays to stimulate the optic nerve, transmitting visual signals to the brain. Animal studies have already demonstrated that these devices can elicit basic visual sensations, such as light perception, contour recognition, and even some sense of pain in the eye.

This innovation marks a significant step forward in medical science, and its potential to revolutionize treatment for visual impairment is immense. The work conducted by Dr. Ren and his team represents not only a technological breakthrough but also a beacon of hope for those who have lost their sight. As the project moves closer to human trials, the world watches closely, eager to see what the future holds for restoring vision through artificial means.

ARM CMM

Arm Portable CMM

Arm Portable CMM

Automated Precision Inc. , https://www.apiasean.com